{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:47:30Z","timestamp":1783730850173,"version":"3.55.0"},"posted":{"date-parts":[[2025,8,21]]},"group-title":"In Review","reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,7,30]]},"abstract":"<title>Abstract<\/title>\n        <p><bold>Background:<\/bold> Retinal hypoxia may contribute to the development of preretinal neovascularization in patients with retinopathy of prematurity (ROP). Ciliary bodies compensate oxygen delivery to the retina, and the levels of hypoxia may vary across the peripheral avascular area in ROP. In this study, we have investigated a direct method for imaging gradient levels of retinal hypoxia at the peripheral avascular retina using a model ROP.\n<bold>Methods. <\/bold>The rat 50\/10 oxygen-induced retinopathy (OIR) model was generated by exposing the newly born Brown-Norway rat pups to a 24 hours alternate cycles of 50% and 10% oxygen for 14 days. We also confirmed the development of neovascularization in this model. HYPOX4 was used as a direct method for imaging gradient levels of retinal hypoxia at the peripheral avascular retina. A separate group of rat OIR pups were used to confirm gradient levels of retinal hypoxia using pimonidazole immunostaining. Gradient levels of retinal hypoxia was analyzed using ImageJ software from fluorescence intensities of HYPOX-4 and Pimonidazole immunostaining.\n<bold>Results<\/bold>: Retinal hypoxia was observed in the peripheral avascular retinas in rat OIR. Based on fluorescence intensity measurements, retinal hypoxia was at minimal levels near the ciliary bodies. Retinal hypoxia was at its maximum levels towards the avascular-vascular transition zones. Interestingly, we observed hemiretinal avascular retina temporal to the optic nerve in this OIR model, similar to human ROP retinas. In the retinal cross-section, hypoxia was not detectable near the ora serrata in rat OIR may be due to oxygen delivery by the ciliary bodies. Both pimonidazole and HYPOX-4 showed similar patterns of retinal hypoxia at the peripheral avascular retina in this model. As expected, preretinal neovascularization was observed at the avascular-vascular transition zones arising from the existing retinal vascular structures in this OIR model in Brown-Norway rats.\n<bold>Conclusions<\/bold>: In this study, we have characterized gradient levels of retinal hypoxia in the rat model of 50\/10 OIR using a direct method from HYPOX-4 fluorescence. We observed minimal levels of retinal hypoxia near the ciliary bodies in this model and increased towards the avascular-vascular transition zones. In addition, we observed that the central vascularized retina remains gradient hypoxic in this model which could be detected using HYPOX-4. This study may clarify our understanding of retinal hypoxia in the ROP patient at the peripheral retinas.<\/p>","DOI":"10.21203\/rs.3.rs-7247191\/v1","type":"posted-content","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:12:34Z","timestamp":1755792754000},"source":"Crossref","is-referenced-by-count":1,"title":["A direct method for imaging\u00a0gradient levels of retinal hypoxia in a model of retinopathy of prematurity (ROP)"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5611-9666","authenticated-orcid":false,"given":"MD Imam","family":"Uddin","sequence":"first","affiliation":[{"name":"Vanderbilt University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Jamal","sequence":"additional","affiliation":[{"name":"Vanderbilt University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Penn","sequence":"additional","affiliation":[{"name":"Vanderbilt University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"26","key":"ref1","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1056\/Nejmra1208129","article-title":"Mechanisms and Management of Retinopathy of Prematurity","volume":"367","author":"Hartnett ME","year":"2012","unstructured":"Hartnett ME, Penn JS. Mechanisms and Management of Retinopathy of Prematurity. New Engl J Med. 2012;367(26):2515\u201326. 10.1056\/Nejmra1208129. PubMed PMID: WOS:000312714200009.","journal-title":"New Engl J Med"},{"issue":"7070","key":"ref2","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/nature04482","article-title":"Retinal angiogenesis in development and disease","volume":"438","author":"Gariano RF","year":"2005","unstructured":"Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature. 2005;438(7070):960\u20136. 10.1038\/nature04482. PubMed PMID: WOS:000233934600055.","journal-title":"Nature"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1172\/JCI42142","article-title":"Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life","volume":"120","author":"Sapieha P","year":"2010","unstructured":"Sapieha P, Joyal JS, Rivera JC, Kermorvant-Duchemin E, Sennlaub F, Hardy P, Lachapelle P, Chemtob S. Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest. 2010;120(9):3022\u201332. PubMed PMID: 20811158; PMCID: PMC2929716.","journal-title":"J Clin Invest"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.survophthal.2022.11.007","article-title":"Retinopathy of prematurity: A review of pathophysiology and signaling pathways","volume":"68","author":"Fevereiro-Martins M","year":"2023","unstructured":"Fevereiro-Martins M, Marques-Neves C, Guimaraes H, Bicho M. Retinopathy of prematurity: A review of pathophysiology and signaling pathways. Surv Ophthalmol. 2023;68(2):175\u2013210. PubMed PMID: 36427559.","journal-title":"Surv Ophthalmol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.001","article-title":"Retinal vasculature development in health and disease","volume":"63","author":"Selvam S","year":"2018","unstructured":"Selvam S, Kumar T, Fruttiger M. Retinal vasculature development in health and disease. Prog Retin Eye Res. 2018;63:1\u201319. PubMed PMID: 29129724.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"ref6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn JS","year":"2008","unstructured":"Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res. 2008;27(4):331\u201371. 10.1016\/j.preteyeres.2008.05.001. Epub 2008\/07\/26.","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"ref7","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon T","year":"1995","unstructured":"Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995;1(10):1024\u20138. 10.1038\/nm1095-1024. Epub 1995\/10\/01.","journal-title":"Nat Med"},{"issue":"1","key":"ref8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.biocel.2009.10.006","article-title":"Proliferative retinopathies: angiogenesis that blinds","volume":"42","author":"Sapieha P","year":"2010","unstructured":"Sapieha P, Hamel D, Shao Z, Rivera JC, Zaniolo K, Joyal JS, Chemtob S. Proliferative retinopathies: angiogenesis that blinds. Int J Biochem Cell Biol. 2010;42(1):5\u201312. 10.1016\/j.biocel.2009.10.006. Epub 2009\/10\/20.","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"ref9","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1167\/iovs.06-0039","article-title":"Automatic retinal oximetry","volume":"47","author":"Hardarson SH","year":"2006","unstructured":"Hardarson SH, Harris A, Karlsson RA, Halldorsson GH, Kagemann L, Rechtman E, Zoega GM, Eysteinsson T, Benediktsson JA, Thorsteinsson A, Jensen PK, Beach J, Stefansson E. Automatic retinal oximetry. Invest Ophth Vis Sci. 2006;47(11):5011\u20136. 10.1167\/iovs.06-0039. PubMed PMID: WOS:000241557500053.","journal-title":"Invest Ophth Vis Sci"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/02713680600599446","article-title":"A method for chorioretinal oxygen tension measurement","volume":"31","author":"Shahidi M","year":"2006","unstructured":"Shahidi M, Shakoor A, Blair NP, Mori M, Shonat RD. A method for chorioretinal oxygen tension measurement. Curr Eye Res. 2006;31(4):357\u201366. PubMed PMID: WOS:000237274400009.","journal-title":"Curr Eye Res"},{"issue":"13","key":"ref11","doi-asserted-by":"publisher","first-page":"7998","DOI":"10.1167\/iovs.13-12318","article-title":"Absolute Retinal Blood Flow Measurement With a Dual-Beam Doppler Optical Coherence Tomography","volume":"54","author":"Dai CX","year":"2013","unstructured":"Dai CX, Liu XJ, Zhang HF, Puliafito CA, Jiao SL. Absolute Retinal Blood Flow Measurement With a Dual-Beam Doppler Optical Coherence Tomography. Invest Ophth Vis Sci. 2013;54(13):7998\u20138003. 10.1167\/iovs.13-12318. PubMed PMID: WOS:000328133800021.","journal-title":"Invest Ophth Vis Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"16752","DOI":"10.1038\/srep16752","article-title":"Inner retinal oxygen metabolism in the 50\/10 oxygen-induced retinopathy model","volume":"5","author":"Soetikno BT","year":"2015","unstructured":"Soetikno BT, Yi J, Shah R, Liu W, Purta P, Zhang HF, Fawzi AA. Inner retinal oxygen metabolism in the 50\/10 oxygen-induced retinopathy model. Sci Rep. 2015;5:16752. 10.1038\/srep16752. PubMed PMID: 26576731; PMCID: 4649746.","journal-title":"Sci Rep"},{"issue":"2","key":"ref13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1006\/gyno.1998.5163","article-title":"Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma","volume":"71","author":"Varia MA","year":"1998","unstructured":"Varia MA, Calkins-Adams DP, Rinker LH, Kennedy AS, Novotny DB, Fowler WC Jr., Raleigh JA. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol. 1998;71(2):270\u20137. 10.1006\/gyno.1998.5163. PubMed PMID: 9826471.","journal-title":"Gynecol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"31011","DOI":"10.1038\/srep31011","article-title":"In Vivo Imaging of Retinal Hypoxia in a Model of Oxygen-Induced Retinopathy","volume":"6","author":"Uddin MI","year":"2016","unstructured":"Uddin MI, Evans SM, Craft JR, Capozzi ME, McCollum GW, Yang R, Marnett LJ, Uddin MJ, Jayagopal A, Penn JS. In Vivo Imaging of Retinal Hypoxia in a Model of Oxygen-Induced Retinopathy. Sci Rep. 2016;6:31011. 10.1038\/srep31011. Epub 2016\/08\/06.","journal-title":"Sci Rep"},{"issue":"9","key":"ref15","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1167\/iovs.16-21187","article-title":"In Vivo Imaging of Retinal Hypoxia Using HYPOX-4-Dependent Fluorescence in a Mouse Model of Laser-Induced Retinal Vein Occlusion (RVO)","volume":"58","author":"Uddin MI","year":"2017","unstructured":"Uddin MI, Jayagopal A, McCollum GW, Yang R, Penn JS. In Vivo Imaging of Retinal Hypoxia Using HYPOX-4-Dependent Fluorescence in a Mouse Model of Laser-Induced Retinal Vein Occlusion (RVO). Invest Ophthalmol Vis Sci. 2017;58(9):3818\u201324. 10.1167\/iovs.16-21187. Epub 2017\/07\/28.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"ref16","doi-asserted-by":"publisher","first-page":"e12883","DOI":"10.1111\/micc.12883","article-title":"Imaging Hypoxia to Predict Primary Neuronal Cell Damage in Branch Retinal Artery Occlusion","volume":"31","author":"Jamal SZ","year":"2024","unstructured":"Jamal SZ, Dieckmann BW, McCollum GW, Penn JS, Jayagopal A, Imam Uddin MD. Imaging Hypoxia to Predict Primary Neuronal Cell Damage in Branch Retinal Artery Occlusion. Microcirculation. 2024;31(7):e12883. 10.1111\/micc.12883. Epub 2024\/08\/31.","journal-title":"Microcirculation"},{"issue":"3","key":"ref17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/eye.2009.306","article-title":"Oxygen-induced retinopathy: a model for vascular pathology in the retina","volume":"24","author":"Scott A","year":"2010","unstructured":"Scott A, Fruttiger M. Oxygen-induced retinopathy: a model for vascular pathology in the retina. Eye. 2010;24(3):416\u201321. 10.1038\/eye.2009.306. PubMed PMID: WOS:000275447200003.","journal-title":"Eye"},{"issue":"6","key":"ref18","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/pr.2012.132","article-title":"The relationship between patterns of intermittent hypoxia and retinopathy of prematurity in preterm infants","volume":"72","author":"Fiore JM","year":"2012","unstructured":"Di Fiore JM, Kaffashi F, Loparo K, Sattar A, Schluchter M, Foglyano R, Martin RJ, Wilson CG. The relationship between patterns of intermittent hypoxia and retinopathy of prematurity in preterm infants. Pediatr Res. 2012;72(6):606\u201312. 10.1038\/pr.2012.132. PubMed PMID: 23037873; PMCID: 4433009.","journal-title":"Pediatr Res"},{"issue":"6","key":"ref19","first-page":"687","article-title":"Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia","volume":"13","author":"Hodgkiss RJ","year":"1998","unstructured":"Hodgkiss RJ. Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia. Anti-Cancer Drug Des. 1998;13(6):687\u2013702. PubMed PMID: WOS:000077238500010.","journal-title":"Anti-Cancer Drug Des"},{"issue":"9","key":"ref20","first-page":"3429","article-title":"Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization","volume":"35","author":"Penn JS","year":"1994","unstructured":"Penn JS, Tolman BL, Henry MM. Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization. Invest Ophthalmol Vis Sci. 1994;35(9):3429\u201335. Epub 1994\/08\/01. PubMed PMID: 8056518.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"ref21","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1203\/00006450-199412000-00007","article-title":"Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat","volume":"36","author":"Penn JS","year":"1994","unstructured":"Penn JS, Henry MM, Tolman BL. Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res. 1994;36(6):724\u201331. 10.1203\/00006450-199412000-00007. Epub 1994\/12\/01.","journal-title":"Pediatr Res"},{"issue":"3","key":"ref22","first-page":"576","article-title":"Variable oxygen exposure causes preretinal neovascularization in the newborn rat","volume":"34","author":"Penn JS","year":"1993","unstructured":"Penn JS, Tolman BL, Lowery LA. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci. 1993;34(3):576\u201385. Epub 1993\/03\/01. PubMed PMID: 8449677.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"ref23","doi-asserted-by":"publisher","first-page":"e11103","DOI":"10.1371\/journal.pone.0011103","article-title":"HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia","volume":"5","author":"Mowat FM","year":"2010","unstructured":"Mowat FM, Luhmann UF, Smith AJ, Lange C, Duran Y, Harten S, Shukla D, Maxwell PH, Ali RR, Bainbridge JW. HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia. PLoS ONE. 2010;5(6):e11103. 10.1371\/journal.pone.0011103. PubMed PMID: 20559438; PMCID: 2885428.","journal-title":"PLoS ONE"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7247191\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7247191\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:07:35Z","timestamp":1759795655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7247191\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":23,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7247191\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,8,21]]},"subtype":"preprint"}}